DNAJC13 p.Asn855Ser mutation screening in Parkinson's disease and pathologically confirmed Lewy body disease patients

O. Lorenzo-Betancor, K. Ogaki, A. I. Soto-Ortolaza, C. Labbe, R. L. Walton, A. J. Strongosky, J. A. van Gerpen, R. J. Uitti, P. J. Mclean, W. Springer, J. Siuda, G. Opala, A. Krygowska-Wajs, M. Barcikowska, K. Czyzewski, A. Mccarthy, T. Lynch, A. Puschmann, I. Rektorova, Y. SanotskyC. Vilariño-Güell, M. J. Farrer, T. J. Ferman, B. F. Boeve, R. C. Petersen, J. E. Parisi, N. R. Graff-Radford, D. W. Dickson, Z. K. Wszolek, O. A. Ross

Research output: Contribution to journalArticlepeer-review

14 Scopus citations

Abstract

Background: Recently, a novel mutation in exon 24 of DNAJC13 gene (p.Asn855Ser, rs387907571) has been reported to cause autosomal dominant Parkinson's disease (PD) in a multi-incident Mennonite family. Methods: In the present study the mutation containing exon of the DNAJC13 gene has been sequenced in a Caucasian series consisting of 1938 patients with clinical PD and 838 with pathologically diagnosed Lewy body disease (LBD). Results: Our sequence analysis did not identify any coding variants in exon 24 of DNAJC13. Two previously described variants in intron 23 (rs200204728 and rs2369796) were observed. Conclusion: Our results indicate that the region surrounding the DNAJC13 p.Asn855Ser substitution is highly conserved and mutations in this exon are not a common cause of PD or LBD among Caucasian populations.

Original languageEnglish (US)
Pages (from-to)1323-1325
Number of pages3
JournalEuropean Journal of Neurology
Volume22
Issue number9
DOIs
StatePublished - Sep 1 2015

Keywords

  • DNAJC13
  • Genetics
  • Lewy body disease
  • Parkinson's disease

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Fingerprint Dive into the research topics of 'DNAJC13 p.Asn855Ser mutation screening in Parkinson's disease and pathologically confirmed Lewy body disease patients'. Together they form a unique fingerprint.

Cite this